{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:27:06Z","timestamp":1791217626808,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1625,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1750-2659.2011.00242.x","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T01:41:35Z","timestamp":1300758095000},"page":"288-295","source":"Crossref","is-referenced-by-count":23,"title":["Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010"],"prefix":"10.1111","volume":"5","author":[{"given":"Lars R.","family":"Haaheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,21]]},"reference":[{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB1|cit1","first-page":"1","article-title":"Laboratory Correlates of Immunity to Influenza - A Reassessment","volume":"115","author":"Brown","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.vaccine.2008.06.012","article-title":"FDA\/NIH\/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007","volume":"26","author":"Eichelberger","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The Role of Serum Haemagglutination-Inhibiting Antibody in Protection against Challenge Infection with Influenza A2 and B Viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB4|cit4","first-page":"63","volume-title":"Laboratory Correlates of Immunity to Influenza - A Reassessment","volume":"115","author":"De Jong","year":"2003"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza","volume":"24","author":"Subbarao","year":"2006","journal-title":"Immunity"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1016\/j.vaccine.2007.08.042","article-title":"Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects","volume":"25","author":"Couch","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/j.vaccine.2010.03.074","article-title":"Report of the fourth meeting on \u2018Influenza vaccines that induce broad spectrum and long-lasting immune responses\u2019, World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009","volume":"28","author":"Stephenson","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB13|cit13","unstructured":"Committee for Medicinal Product for Human Use (CHMP) Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines 2010 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/08\/WC500095721.pdf"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/596558","article-title":"A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults","volume":"199","author":"Karron","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2009.03.082","article-title":"A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults","volume":"27","author":"Talaat","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.vaccine.2009.05.099","article-title":"Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults","volume":"27","author":"Karron","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza A\/H3N2 viruses: an international collaborative study","volume":"25","author":"Stephenson","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3201\/eid1508.081754","article-title":"Reproducibility of serologic assays for influenza virus A (H5N1)","volume":"15","author":"Stephenson","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB20|cit20","first-page":"43","article-title":"Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza","volume":"52","author":"Schild","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/cyto.a.20613","article-title":"FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity","volume":"73","author":"van Baalen","year":"2008","journal-title":"Cytometry A"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(90)90255-T","article-title":"Measurement of anti-influenza neuraminidase antibody using peroxidase-linked lectin and microtiter plates coated with natural substrates","volume":"135","author":"Lambr\u00e9","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.vaccine.2009.10.066","article-title":"A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses","volume":"28","author":"Hassantoufighi","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"15ra5","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus","volume":"2","author":"Khurana","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-3527(09)73002-7","article-title":"Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses","volume":"73","author":"Belser","year":"2009","journal-title":"Adv Virus Res"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/595984","article-title":"Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques","volume":"199","author":"Kreijtz","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1086\/322664","article-title":"The ethical challenge of infection-inducing challenge experiments","volume":"33","author":"Miller Franklin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-3-540-92165-3_21","article-title":"Vaccines for pandemic influenza: summary of recent clinical trials","volume":"333","author":"Keitel","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/656601","article-title":"A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults","volume":"202","author":"Talaat","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"e15559","DOI":"10.1371\/journal.pone.0015559","article-title":"Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza","volume":"5","author":"Landry","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"e11601","DOI":"10.1371\/journal.pone.0011601","article-title":"Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA","volume":"5","author":"Zimmer","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1750-2659.2011.00242.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.vaccine.2010.02.076","article-title":"Standardization and validation of assays determining cellular immune responses against influenza","volume":"28","author":"Gijzen","year":"2010","journal-title":"Vaccine"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1750-2659.2011.00242.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1750-2659.2011.00242.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:21:58Z","timestamp":1625570518000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1750-2659.2011.00242.x"}},"subtitle":["Immune correlates of protection against influenza"],"short-title":[],"issued":{"date-parts":[[2011,3,21]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1750-2659.2011.00242.x","relation":{},"ISSN":["1750-2640"],"issn-type":[{"value":"1750-2640","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,21]]}}}